+499.5%
MRNA vs DBX
+20.4%
+479.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DBX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.4% | +0.2% | -1.8% |
| 7D | +5.5% | -2.4% | +7.9% | +5.9% |
| 30D | +158.7% | -0.5% | +159.2% | +158.5% |
| 3M | +182.1% | +28.1% | +154.1% | +165.2% |
| 6M | +151.8% | +33.1% | +118.7% | +132.5% |
| YTD | +393.6% | +25.3% | +368.3% | +358.0% |
| 1Y | +499.5% | +18.3% | +481.1% | +465.6% |
| All | +499.5% | +20.4% | +479.0% | +465.6% |
Cumulative growth
Daily Returns
Daily percentage return beside DBX.
Daily Out/Under-Performance
Portfolio return minus DBX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DBX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DBX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling